At InkVivo we combine our patented biomaterial platform with our advanced manufacturing approach to produce delivery systems that ensure a temporal controlled release of active ingredients (e.g., small molecules, biologics, and micronutrients). With our platform technology we cover a broad range of clinical challenges in the pharma and nutraceutical field. Initially, we focus on gastric delivery systems.
InkVivo's USP is to support our partners to develop new drug delivery systems; to repurpose and reformulate existing drugs; and to extend the lifecycle of patent expiring products. Overall, InkVivo's biofabrication strategy has the potential to improve a broad range of products used in our daily life with a special focus on health, nutrition, and sustainability.
Location: Switzerland, Zurich
Investors 1
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 23.01.2023 | CH 40,000 for a novel drug delivery system to prevent stenos... | ArtemiX Biotech: a novel drug delivery system to prevent stenosis Chronic kidney disease (CKD) is a... | venturekic... |
| 12.10.2022 | Fifteen Talent Kick projects enter the next level | The Talent Kick program went live last November to help masters and PhD students across ETH Zürich... | startuptic... |
| 27.09.2022 | Startups turning waste into value, developing an innovative ... | Gaia Technologies: Turning waste into value The cosmetic, food, and pet food industries eagerly loo... | venturekic... |
| 17.06.2022 | Venture Day Basel presents 18 startups | Organised by Startup INVEST in collaboration with Plug and Play Basel and uptownBasel, Venture Day... | startuptic... |
| 20.05.2022 | Startup Days break a record | The first Startup Days gathering after the pandemic was very well attended. 1200 entrepreneurs, in... | startuptic... |